Steven Stice, PhD, Chairman of the Board, Chief Scientific Officer and Co-Founder
Dr. Stice is a co-founder of ArunA and serves as its Chief Scientific Officer in a consulting capacity. He is responsible for the scientific direction, including grant development, monitoring new and potentially competitive technologies and intellectual property protection. Dr. Stice has over 20 years of research and development experience in biotechnology and has helped found five biotechnology companies (InfiGen, Advanced Cell Technology, ProLinia, Cytogenesis, and Aruna). In 2001, as a consultant to BresaGen Inc., he led the team that produced the world’s first hESC derived from discarded embryos. Three of these lines are on the NIH registry of 21 approved hESC lines for NIH funding. Dr. Stice has published his work on both primate and human neural progenitor derivation from hESC cells. He has over twenty granted patents relavent to human stem cell and cloning technologies and six patent applications pending. Dr. Stice has received extensive recognition for his work in cloning and stem cell research from publications in Science and Nature to national news coverage for his cloning work. In 1998, Dr. Stice joined the University of Georgia as a Georgia Research Alliance Eminent Scholar Endowed Chair and serves as Professor and Director of Georgia’s Regenerative Bioscience Center. The University of Georgia Research Foundation awarded Dr. Stice with the prestigious Inventor of the Year award in 2005. He was named one of the most influential Georgians by Georgia Trend magazine and in 2000 Dr. Stice was named one of the top forty entrepreneurs under 40 years old in Georgia. He currently directs a group of 12 scientists working on human stem cell research at UGA.
Harold "Bud" Ingalls, Director
Mr. Ingalls brings nearly 40 years of financial leadership to ArunA and during his career he has served in the capacity of chief financial officer for nearly two decades. Most recently, Mr. Ingalls served as Chief Financial Officer of Premier Exhibitions, Inc. (NASDAQ: PRXI) and prior to he served as Vice President and Chief Financial Officer at CardioMEMS, where he played a key role in the organization’s transformation, directly supervising accounting operations and overseeing all compliance issues. This led to the completion of two private financing rounds totaling over $45.0 million with venture capitalists and strategic investors. From 2001 to 2006, Mr. Ingalls served as the Vice President of Finance and Chief Financial Officer of Serologicals Corporation where he helped increase enterprise value by almost $1.0 billion as the result of strong organic growth, successful acquisitions and stringent cost control. Prior to his work with Serologicals, he was employed as President and Chief Financial Officer of LaRoche Industries, Inc. Mr. Ingalls is a member of the American Institute of Certified Public Accountants. He received a BBA degree in Accounting from the University of Wisconsin.
C. William "Bill" Griffin, Director
Bill Griffin brings more than 34 years experience in the mortgage finance and financial service fields to ArunA's elite team of Directors. He is the managing director of Fidelity National Information Services, the nation's leading provider of financial services technology and mortgage-related services. His career in mortgage finance began in 1972 with Citizens & Southern National Bank in Atlanta, where he spent three years. In 1975, Griffin joined Ticor Mortgage Insurance, where in nine years he assumed an assortment of responsibilities, including managing sales and marketing, secondary marketing, operations and risk management. He also served on the mortgage insurance company's board of directors and was president and CEO of Ticor Securities Co.
In 1984, Griffin moved to Dallas and founded Highland Park National Bank and its mortgage subsidiary, the Highland Capital Group. Three years later, he co-founded the Stratmor Group, a privately held investment banking firm. In 1989, Griffin joined Lender's Service Incorporated (LSI), again applying his talents in a number of departments. His tenure at LSI culminated when he was appointed chief executive officer and president prior to the company's acquisition by Fidelity National Information Services in 2003. As managing director of Fidelity National, Griffin is responsible for leading the company's efforts to provide services to the largest financial institutions in the world.
Mr. Griffin's civic involvement includes, among others, serving on the Board of Overseers and the Campaign Steering Committee for the Terry College where he received his bachelor’s degree in 1972.
Darren W. DeVore, Director
Darren W. DeVore is the managing partner of Broad Pine Investments, the holding company for his various private equity and venture capital activities. Broad Pine maintains investments in several businesses including, Origin Development Group, The Carroll Organization, Terra Partners, Puzzle Social, Aruna Biomedical and the Battle Investment Group.
Prior to the formation of Broad Pine Investments, Darren spent 14 years as a Managing Director of Artisan Partners LP, a leading global investment management firm. There he designed and implemented marketing and client service strategies that grew the firm from $800 million to $65 billion in assets under management. He started his career at Pacific Financial Asset Management Corporation (presently known as PIMCO Advisors) where his responsibilities included launching the Scottish investment firm, Blairlogie Capitol Management.
Darren is the founding board chairman of Mt. Bethel Christian Academy. A graduate of University of Georgia, Darren is a member of the Terry College of Business Dean’s Advisory Council, and a trustee with the University of Georgia Foundation.